Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
January 1, 2017Problems of Particularly Dangerous InfectionsOpen Access

Immunomodulators and Specific Prophylaxis of Infectious Diseases

View Full Paper
Ask AI
Bookmark
Share

Authors

NON. D. OmelchenkoRostov-on-Don Anti-plague Institute RospotrebnadzorIIIvanova IaRostov-on-Don Anti-plague Institute RospotrebnadzorBIBespalova IaFederal Reserve

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Omelchenko et al. (2017) studied this question.

synapsesocial.com/papers/6a15af105347fbb173a023dahttps://doi.org/10.21055/0370-1069-2017-3-21-26
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 2 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Intranasal Administration of an Inactivated Yersinia pestis Vaccine with Interleukin-12 Generates Protective Immunity against Pneumonic Plague2011 · 12 citations
  2. 2Inactivated<i>Francisella tularensis</i>Live Vaccine Strain Protects against Respiratory Tularemia by Intranasal Vaccination in an Immunoglobulin A-Dependent Fashion2007 · 87 citations